Divalproex Sodium
Product Images NDC 21695-817

8 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 21695-817). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium Structure (9b3db659 F64c 4c48 946a 6b4f1d800eba 01)

Divalproex Sodium Structure (9b3db659 F64c 4c48 946a 6b4f1d800eba 01)
Chemical structure of the active ingredient in Divalproex Sodium DR, depicting the molecular arrangement with sodium ion and carbon chains labeled.*
FDA Label Image

Figure 1 Percentage Of Patients Achieving ≥ 30% Reduction In Symptom Score From Baseline (9b3db659 F64c 4c48 946a 6b4f1d800eba 02)

Figure 1 Percentage Of Patients Achieving ≥ 30% Reduction In Symptom Score From Baseline (9b3db659 F64c 4c48 946a 6b4f1d800eba 02)
A bar chart comparing percentage values on the y-axis between PBO and DVPX groups across two studies. Study 1 uses YMRS metrics while Study 2 uses MRS metrics, showing higher percentages for the Divalproex Sodium DR (DVPX) group compared to placebo (PBO).*
FDA Label Image

Figure 2 Mean 4-week Migraine Rates (9b3db659 F64c 4c48 946a 6b4f1d800eba 03)

Figure 2 Mean 4-week Migraine Rates (9b3db659 F64c 4c48 946a 6b4f1d800eba 03)
A bar graph comparing placebo and Divalproex Sodium delayed-release tablets in two studies. The vertical axis represents a numerical scale from 0 to 6, showing higher values for placebo groups versus Divalproex Sodium groups in both Study 1 and Study 2.*
FDA Label Image

Figure 3 Presents Proportion Of Patients In The Adjunctive Therapy Study (9b3db659 F64c 4c48 946a 6b4f1d800eba 04)

Figure 3 Presents Proportion Of Patients In The Adjunctive Therapy Study (9b3db659 F64c 4c48 946a 6b4f1d800eba 04)
A cumulative distribution plot showing percentage reduction in CPS rates for patients taking Divalproex Sodium Delayed-Release Tablets versus placebo. The x-axis represents the percentage of patients, and the y-axis shows the percent reduction in CPS rate, with markers for worsening and no change.*
FDA Label Image

Figure 4 Presents Proportion Of Patients In The Monotherapy Study (9b3db659 F64c 4c48 946a 6b4f1d800eba 05)

Figure 4 Presents Proportion Of Patients In The Monotherapy Study (9b3db659 F64c 4c48 946a 6b4f1d800eba 05)
A cumulative distribution plot comparing percent reduction in CPS rate against percent of patients for Divalproex Sodium DR. Two lines represent High Dose and Low Dose groups, showing patient improvement or worsening based on CPS rate change.*
FDA Label Image

Divalproex Sodium 125mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 06)

Divalproex Sodium 125mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 06)
Label for Divalproex Sodium 125mg delayed-release (DR) tablets, package of 60, from Physician Partner, a division of Rebel Distributors Corp. The label states each tablet contains valproic acid equivalent to 125mg and describes the tablet as lavender colored, oval shaped, biconvex, enteric coated with black ink imprint 'L005' on one side. Packaged by Physician Partner in Thousand Oaks, CA, with manufacturing by Lupin Limited, Mumbai, India.*
FDA Label Image

Divalproex Sodium 250mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 07)

Divalproex Sodium 250mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 07)
Label for Divalproex Sodium 250 mg DR Tablets, bottle of 60 tablets, indicating lavender-colored, oval-shaped, biconvex, enteric-coated tablets with imprint 'L06'. Packaged by Physician Partner, Thousand Oaks, CA. Manufacturer Lupin Limited, Mumbai, India. Includes storage instructions and lot/expiration placeholders.*
FDA Label Image

Divalproex Sodium 500mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 08)

Divalproex Sodium 500mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 08)
Label for Divalproex Sodium 500mg DR Tablets, bottle of 60 tablets. The label indicates each tablet contains divalproex sodium USP equivalent to 500mg valproic acid. Manufactured by Lupin Limited Mumbai, India, and packaged by Physician Partner, Thousand Oaks, CA. The label includes directions for storage and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.